Johns Hopkins ABX Guide
Cefotetan
Cefotetan is a topic covered in the Johns Hopkins ABX Guide.
To view the entire topic, please log in or purchase a subscription.
Official website of the Johns Hopkins Antibiotic (ABX), HIV, Diabetes, and Psychiatry Guides, powered by Unbound Medicine. Johns Hopkins Guide App for iOS, iPhone, iPad, and Android included. Explore these free sample topics:
-- The first section of this topic is shown below --
INDICATIONS
FDA
FDA
- Urinary tract infections
- Lower respiratory tract infections
- Skin and skin structure infections
- Gynecologic infections, including PID (note: no activity against C. trachomatis)
- No longer recommended in 2022 STD Guideline.
- Intra-abdominal infections (IDSA guidelines: cefotetan is no longer recommended for intra-abdominal infections as monotherapy due to high rates of B. fragilis resistance).
- Bone and joint infections (author’s comment: generally used for mild infections)
- Surgical prophylaxis (e.g., cesarean section, abdominal or vaginal hysterectomy, trans-urethral surgery, biliary tract surgery, and gastrointestinal surgery)
NON-FDA APPROVED USES
NON-FDA APPROVED USES
- Uncomplicated cholangitis
-- To view the remaining sections of this topic, please log in or purchase a subscription --
INDICATIONS
FDA
FDA
- Urinary tract infections
- Lower respiratory tract infections
- Skin and skin structure infections
- Gynecologic infections, including PID (note: no activity against C. trachomatis)
- No longer recommended in 2022 STD Guideline.
- Intra-abdominal infections (IDSA guidelines: cefotetan is no longer recommended for intra-abdominal infections as monotherapy due to high rates of B. fragilis resistance).
- Bone and joint infections (author’s comment: generally used for mild infections)
- Surgical prophylaxis (e.g., cesarean section, abdominal or vaginal hysterectomy, trans-urethral surgery, biliary tract surgery, and gastrointestinal surgery)
NON-FDA APPROVED USES
NON-FDA APPROVED USES
- Uncomplicated cholangitis
There's more to see -- the rest of this topic is available only to subscribers.
Last updated: October 18, 2022
Citation
Auwaerter, Paul G, and Edina Avdic. "Cefotetan." Johns Hopkins ABX Guide, The Johns Hopkins University, 2022. Johns Hopkins Guide, www.hopkinsguides.com/hopkins/view/Johns_Hopkins_ABX_Guide/540096/all/Cefotetan.
Auwaerter PG, Avdic . Cefotetan. Johns Hopkins ABX Guide. The Johns Hopkins University; 2022. https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_ABX_Guide/540096/all/Cefotetan. Accessed November 30, 2022.
Auwaerter, P. G., & Avdic, . (2022). Cefotetan. In Johns Hopkins ABX Guide. The Johns Hopkins University. https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_ABX_Guide/540096/all/Cefotetan
Auwaerter PG, Avdic . Cefotetan [Internet]. In: Johns Hopkins ABX Guide. The Johns Hopkins University; 2022. [cited 2022 November 30]. Available from: https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_ABX_Guide/540096/all/Cefotetan.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Cefotetan
ID - 540096
A1 - Auwaerter,Paul,M.D.
AU - Avdic, Edina,Pharm.D.
Y1 - 2022/10/18/
BT - Johns Hopkins ABX Guide
UR - https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_ABX_Guide/540096/all/Cefotetan
PB - The Johns Hopkins University
DB - Johns Hopkins Guide
DP - Unbound Medicine
ER -
